Paper36724239
Additive efficacy of a bispecific anti-TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis.
Biesemann N and 15 others. Sci Transl Med, 2023. Cited by 66 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Additive efficacy of a bispecific anti-TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis. Papers, record 36724239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36724239
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Additive efficacy of a bispecific anti-TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Experimental | Major topic |
| Arthritis, Rheumatoid | Major topic |
| Synoviocytes | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Cells, Cultured | |
| Fibroblasts | |
| Synovial Membrane | |
| Tumor Necrosis Factor Inhibitors | |
| Tumor Necrosis Factor-alpha | |
| Interleukin-6 |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 36894778 | Nanobody targets TNF and IL-6 for additive efficacy. | https://conductscience.org/library/papers/36894778 |
Source PubMed
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42890560 | Engineering Tripterygium wilfordii-derived exosome-like nanoparticles for targeted therapy in rheumatoid arthritis. | Extracell Vesicles Circ Nucl Acids | 2026 | https://conductscience.org/library/papers/42890560 | PubMed |
| 42865714 | Sanguinarine ameliorates rheumatoid arthritis by activating the Hippo-YAP/TAZ pathway to induce apoptosis and suppress inflammation in fibroblast-like synoviocytes. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42865714 | PubMed |
| 42798472 | Combination of Chenpi and Banxia alleviates synovial inflammation in a rat model of rheumatoid arthritis by targeting the JNK/AP-1 signaling pathway. | Front Immunol | 2026 | https://conductscience.org/library/papers/42798472 | PubMed |
| 42620704 | Transcending aging: disease specificity, assessment challenges, and management strategies for rheumatoid arthritis-related sarcopenia. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42620704 | PubMed |
| 42312209 | Stress-induced IL-6 regulation in pediatric bone growth disorders: current insights and therapeutic strategies. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42312209 | PubMed |
| 42080357 | A Nanobody-LNP Platform for Targeting and Relicensing Dendritic Cells for Potent Cancer Immunotherapy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42080357 | PubMed |
| 41978838 | Kadsua coccinea Extract Alleviates Rheumatoid Arthritis via TNF-α Suppression and Gut Microbiota Modulation. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/41978838 | PubMed |
| 41972141 | Mechanisms of inflammation in premature ovarian insufficiency and advances in therapeutic studies. | Front Immunol | 2026 | https://conductscience.org/library/papers/41972141 | PubMed |
| 41832600 | Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation. | Mol Ther | 2026 | https://conductscience.org/library/papers/41832600 | PubMed |
| 41752950 | Microvascular Genesis of Diseases: From Hypothesis to Theory. | Life (Basel) | 2026 | https://conductscience.org/library/papers/41752950 | PubMed |
| 41752211 | A Study on the Treatment of Rheumatoid Arthritis Using a Novel GelMA-HAMA Dual-Network Hydrogel Microneedle Loaded with MTX-NCs in Combination with Adalimumab. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41752211 | PubMed |
| 41619129 | Emerging Therapeutics in Rheumatoid Arthritis. | Curr Rheumatol Rep | 2026 | https://conductscience.org/library/papers/41619129 | PubMed |
| 41595435 | Transcriptome Profiling of the Anterior Cingulate Cortex in a CFA-Induced Inflammatory Pain Model Identifies ECM-Related Genes in a Model of Rheumatoid Arthritis. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/41595435 | PubMed |
| 41524227 | Antibody-Empowered Nanomedicine for Precise Biomedical Applications. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41524227 | PubMed |
| 41153712 | Effects of Janus Kinase Inhibitors on Rheumatoid Arthritis Pain: Clinical Evidence and Mechanistic Pathways. | Biomedicines | 2025 | https://conductscience.org/library/papers/41153712 | PubMed |
| 40988741 | Safety of Sarilumab in the treatment of rheumatoid arthritis: a real-world study based on the FAERS database. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40988741 | PubMed |
| 40932933 | Critical signaling pathways in osteoclast differentiation and bone resorption: mechanisms and therapeutic implications for periprosthetic osteolysis. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40932933 | PubMed |
| 40809131 | Building virtual patients using simulation-based inference. | Front Syst Biol | 2024 | https://conductscience.org/library/papers/40809131 | PubMed |
| 40707975 | Targeting rheumatoid arthritis: a molecular perspective on biologic therapies and clinical progress. | J Biol Eng | 2025 | https://conductscience.org/library/papers/40707975 | PubMed |
| 40662067 | Integrating clinical features, inflammatory markers, and immune profiles: a Yunke-based nomogram model for rheumatoid arthritis prognosis. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40662067 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL6R | 3570 | PubTator's text mining | https://conductscience.org/library/genes/3570 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36724239
GET https://conductscience.org/api/papers/v1/36724239/cited_by?page=2